Purpose. To review the past and current literature and present recent findings on orthokeratology and corneal refractive therapy. Methods. Various articles on contact lens corneal reshaping were analyzed. Common clinical procedures and interference measurement of tear-film thickness were also used. Results. Although the numbers of patients tested to date do not allow conclusions of great certainty, based on a review of the current literature, our recent study of 60 patients, and the Food and Drug Administration approval of overnight contact lens corneal refractive therapy, there is a low incidence of complications, and unaided visual acuity of 20/20 in the morning is possible in most (74%) successful cases. Refractive error change of 2.25diopter (D) Ϯ 1.00D is common. A presumed iron ring may appear in some patients in the midperipheral corneal epithelium. Conclusion. Overnight orthokeratology and corneal refractive therapy with modern design reverse-return zone lenses in high-Dk rigid gas-permeable contact lens materials is an option for transient vision correction for some myopic patients.
According to Winkler and Kame, 1 Newton Wesley described spectacle blur with contact lenses in the 1950s. Nolan 2 writes that Jessen described ortho-focus in 1962, whereas May and Grant 2 wrote about emmetropization through contact lenses in 1964. In an obscure publication in 1972, Fontana 3 described a contact lens for orthokeratology that had a secondary curve that was steeper than the base curve. Kerns, 4 in 1976, using polymethylmethacrylate (PMMA) contact lenses, reported on 36 orthokeratology eyes of 18 patients (baseline spherical equivalent, Ϫ2.11 diopter [D]; range, Ϫ0.87D to Ϫ3.50D). He found a mean decrease in myopia of 1.06D Ϯ 0.98D, (range, 3.00D fewer to 0.75D more in myopia). He also reported a trend toward an increased with-the-rule astigmatism of 0.42D Ϯ 0.74D, (range, 0.25D against-the-rule to 3.00D with-the-rule). Unaided Snellen visual acuity was 20/20 or better at the end of therapy in 64% of eyes, but only 12% of eyes had visual acuity of 20/20 or better 7 days after discontinuation of lens wear. Adverse events, including abrasion, were not observed. Lens centration in fitting was determined to be important to prevent adverse refractive changes (i.e., astigmatism and distortion). Kerns ' data indicate that it took approximately 300 days to maximize the treatment using PMMA lenses for daily wear, fitted an average of 0.62D flatter than the flat keratometric reading. 4 In the early 1980s, The National Eye Institute sponsored a clinical trial on orthokeratology at Berkeley, performed by Polse et al., 5 that used PMMA and low-oxygen flux rigid contact lenses worn during waking hours. The spherical equivalent refractive error was reduced by 1.00D in the treatment group (n ϭ 31; average of Ϫ2.70D Ϯ 1.10D of myopia at baseline) compared with 0.54D for the control group (n ϭ 28), (two-sample t test; P ϭ 0.02). These changes regressed toward more myopic refractive error by 45% after 15 days of reduced contact lens wearing time, demonstrating the transient nature of the procedure. Unaided log of minimal angle of resolution visual acuity improved on average from 0.75 to 0.45 (or slightly worse than 20/125 to approximately 20/70) in the treatment group. Few clinically significant adverse corneal reactions were reported. 5 Binder et al. 6 reported highly variable, transient results and an average of 1.60D of myopia reduction with orthokeratology after 12 months. This group had an average of Ϫ2.50D of myopia (range, Ϫ1.50D to Ϫ4.80D) before treatment. Two groups of orthokeratology patients were described. The higher myopia group achieved an average of 20/45 uncorrected visual acuity, and the lower myopia group achieved an average of 20/25 uncorrected visual acuity. However, the improved visual acuity did not last for more than hours or days in either group. Binder et al. 6 also reported that there was no abnormal incidence of corneal abrasion but that all orthokeratology patients who had improved unaided visual acuity complained about the quality of their vision. These studies were all performed with traditional contact lens designs that gradually flatten from the base curve to the edge. Mountford 7 studied 60 patients using the overnight orthokeratology procedure with a mean baseline refractive error of Ϫ2.19D Ϯ 0.79D. He found a mean resultant refractive error of 0.00D Ϯ 0.68D. Mountford 7 proposed a model that assumed a corneal eccentricity of 0.5 and predicted an average reduction in myopia of 2.50D. These changes occur in days to 3 weeks, unlike the 300 days reported by Kerns. Nichols et al. 8 used rigid gaspermeable (RGP)-reverse geometry lenses in a study of overnight orthokeratology and found a mean change in spherical equivalent refraction of Ϫ1.83 Ϯ 1.23. At day 60, 87% of the subjects were able to achieve visual acuity of 20/30. They also reported clinically significant fluorescein staining of the cornea in a few of their subjects, which resolved when the lenses were removed and did not require treatment; however, one subject was discontinued from the study as a result of the corneal staining. Nichols et al. 8 also reported central corneal thinning from baseline to the studies end in their cohort.
It is important to note that the current orthokeratology technique is vastly different from that used during the early 1980s and earlier. High-Dk RGP contact lens materials offer several advantages over PMMA. Reverse or return zone geometry posterior surface lenses (base curve is flatter than the secondary curve) provide lenses with improved ability to mold to the central cornea. These lenses center better on the cornea than previous orthokeratology lens designs, providing a more regular corneal molding. Advances in computeraided design and computer numeric-controlled, automated lathes used to manufacture RGP contact lenses make this possible. Figure  1 illustrates a return-zone design lens on the author's cornea. Table  1 summarizes results of a number of contact lens corneal reshaping studies. 9
U. S. GOVERNMENT REGULATION OF CONTACT LENS CORNEAL RESHAPING
U. S. government agencies have taken a number of steps to establish guidelines and regulate orthokeratology. The Federal Aviation Administration (V. B. Nakagawara, personal communication) does not stop pilots from flying after undergoing orthokeratology. However, the use of orthokeratology is not acceptable for Air Terminal and Air Control Center positions. In 1997 and 1998, the Federal Trade Commission (FTC) investigated two optometrists for alleged false guarantees about the effectiveness of orthokeratology. The FTC web site (www.ftc.gov/bcp/conline/ pubs/health/vision.htm) indicates that 68 million Americans are nearsighted and that refractive surgery and orthokeratology are not always shortcuts to perfect vision. It refers to "Ortho-K" as a nonsurgical procedure and states that there is no new scientific evidence to substantiate the claims that new orthokeratology methods are better than those of previous published scientific literature. It further states that 15% of refractive surgery patients still need correction for distance vision and that 95% of refractive surgery patients achieve unaided visual acuity of 20/40 or better, implying there is some question about the efficacy of both of these procedures. This web site is outdated at this time. The Contex, Inc., RGP "OK" lens (Stoyan, Sherman Oaks, CA) was approved by the Food and Drug Administration (FDA) in May 1998 for daily wear. It is indicated for daily wear for temporary reduction of myopia up to 3.00D. Later, several other designs were approved for daily wear. In June 2002, the FDA approved the Paragon Vision Sciences (Mesa, AZ) Paragon CRT lens for overnight contact lens corneal refractive therapy for up to 6D of myopia reduction with no age restrictions. Some prefer to call this procedure overnight orthokeratology, and some prefer the term contact lens corneal refractive therapy or contact lens corneal reshaping.
THE LENSES AND OVERNIGHT ORTHOKERATOLOGY STUDY
The Lenses and Overnight Orthokeratology (LOOK) study is a multicenter (The Ohio State University College of Optometry, Columbus, OH, The New England College of Optometry, Boston, MA, and The Southern California College of Optometry, Memphis, TN), prospective cohort pilot study designed to learn the procedures of orthokeratology lens fitting in preparation for a larger clinical trial and to obtain data to calculate a sample size for that larger study. Preliminary data are reported here after 3 months of treatment from 60 patients fitted with two designs of RGP lenses for overnight orthokeratology (the FARGO 6 [GP Specialists, Phoenix, AZ] and the Paragon CRT lenses).
Each patient read and signed an informed consent form according to local institutional review board protocol, which was also signed and dated by the investigator. The study was conducted in accordance with the Declaration of Helsinki. Because overnight orthokeratology was not an FDA-approved procedure at the time of data collection, this study was performed under the FDA Investigational Device Exemption #G990205. Tables 2 and 4 summarize the results of the LOOK study. 9 In summary, the LOOK study found that of the 60 subjects enrolled, 46 completed the 1-month visit, and 31 completed the 3-month visit. The mean change in spherical equivalent manifest refraction from baseline to the morning 3-month visit was 2.08D Ϯ
FIG. 2.
Presumed iron ring in an overnight corneal refractive therapy and orthokeratology patient. 
Serious Complications in Overnight Orthokeratology
Although rare and not yet reported in the United States, occasional serious adverse events have been reported in conjunction with orthokeratology contact lens wear. A case of a 9-year-old boy in Taiwan who experienced a corneal ulcer after approximately 8 months of lens wear was reported. 10
Presumed Iron Deposition
Deposition, presumably of iron (hemosiderin), was found in the corneal epithelium in a series of patients (some in the LOOK Study and some fitted off label) who have been undergoing treatment with overnight orthokeratology for 6 months to 2 years ( Figure 2 ).
Paragon CRT lenses were worn by four patients, the DreimLens (DreimLens, Inc., FL) was worn by one patient, and one patient initially began treatment in the FARGO 6 lens design and ultimately was refitted into Paragon CRT lenses. The finding was more prominent in patients with dark irides and in patients with higher baseline refractive errors. Although this is an interesting finding, it does not seem to affect visual acuity, nor does it seem to be adverse in nature. All six patients still chose to undergo treatment with overnight orthokeratology and corneal refractive therapy. 11 Presumed iron deposition in the corneal epithelium was present in five of six cases of overnight orthokeratology lens wear in this sample of patients. We do not imply that this is the expected prevalence of this condition. This finding is in agreement with previous literature on surgical corneal refractive procedures. We believe this is a non-sight-threatening, nonclinically significant event. Consistent with other types of pigment lines, the pigmentation does not interfere with the visual axis and does not alter visual acuity in these patients; therefore, no treatment has been necessary. All of the patients were informed of their condition, and none of the patients chose to discontinue their overnight orthokeratology treatment. We hypothesize that on discontinuation of contact lens wear, the cornea will return to a normal level of 
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corneal exfoliation, and the deposition of iron will slough off with the corneal cells over time. Further studies are necessary to determine whether or not this will indeed occur and to determine the epidemiology and origin. Probably the most plausible hypothesis is that epithelial turnover is reduced in all contact lens wearers. 12 Orthokeratology results in redistribution of corneal epithelium; the central corneal epithelium thins, and the midperipheral corneal epithelium thickens. 13 The decreased rate of desquamation seen in typical contact lens wear coupled with the increased thickness of the epithelium in this area because of the orthokeratology lens design may provide for cellular and tear stasis. This stasis most likely causes an increased rate of basal cell retention. This higher rate, in turn, may result in more iron deposition in the midperipheral thickened area of the epithelium.
Interferometry Measurement of Tear Layer Thickness Behind Corneal Refractive Therapy Lenses
The author's calculation of central tear layer thickness behind return-reverse zone contact lenses on theoretical corneal shapes yields tear layer thickness from 20 m to Ϫ20 m. Mountford et al. 14 assumes a 5-m tear thickness centrally in his design. 14 We attempted to measure the tear-film thickness over the visual axis of the lens pictured in Figure 1 using King-Smith's method. 15 In 16 of 20 trials, no signal was detected, indicating a tear film of less than 2 m. The average thickness during the four trials when a signal was detected was 2.4 Ϯ 4.4 m. We hypothesize that during strong blinks, there is some tear film pumped behind the lens, but during most of the time when the lens is on the eye, it is in close proximity to the corneal surface.
CONCLUSIONS
The mechanism of corneal change in overnight contact lens corneal reshaping is not established, although corneal epithelial migration and compression are implicated. The long-term effects and daily duration of improved vision is not well researched. Not all candidates succeed. Yet, the procedure, when performed carefully and successfully, can provide improved unaided vision for the majority of patients during their work day and for their hobbies; to date, the procedure seems to be safe enough for FDA approval. The authors find that active patients who enjoy sports and outdoor activities and water sports who have had little success with contact lenses worn during the day and who do not want refractive surgery are good candidates for the procedure. It can be performed in one eye for myopic patients who are presbyopic for monovision correction. More research is needed to understand the real safety of this procedure. Data represent the percentage of patients who presented with corneal staining, imprinting from the rigid lenses, and corneal microcysts at the morning and afternoon visits. 
